Background: Amlodipine is a commonly prescribed anti-hypertensive in clinical practice. Gingival overgrowth is a rare side effect of this
INTRODUCTION
Calcium channel blockers (CCBs) are commonly prescribed anti-hypertensive medication with some notable adverse effects like headache, dizziness, facial flushing, oedema. and patients who had discontinued using amlodipine for more than 1 month prior to the study were excluded. progressing to the attached gingiva which may cover the crown. 6 All cases were treated with non-surgical periodontal therapy.
MATERIALS AND METHODS
The collected data was entered and analyzed using SPSS version 22 and inference was taken using Chi-square test. The statistical significance was interpreted based on confidence interval of 95% with 5% standard error.
RESULTS
Out of 507 patients under amlodipine, 240 met the inclusion criteria for the study. Mean age was 49.69±8.1 years. Among total cases, 45% were females and rest being males ( Figure   1 ). There were some comorbidities in 85 (35.4%), rest 155
did not present any comorbidities other than hypertension.
The commonest comorbidity was diabetes mellitus (Table   1 ). Gingival overgrowth was present in 6 (2.5%) of the hypertensive cases under amlodipine while the rest 234 (97.5%) cases did not present with gingival overgrowth ( Figure   2 ). GO was not significantly associated with gender whereas there was a significant association with the dose and duration of amlodipine (p<0.05, OR >1) ( Table 2) . 
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DISCUSSION
The prevalence of amlodipine induced gingival overgrowth was 2.5% in this study which is comparable to those reported in literature of 1.3%, 1 1.4%, 3 3.3%, 8 3.4%. 10 All patients in this study were under amlodipine for six months or more. Drug duration and dosage were significantly associated with DIGO 2 by T cells, 4,9 IL-6 and production of growth factors like transforming growth factor beta (TGFβ), basic fibroblast growth factor (βFGF) which enhances proliferation of connective tissue fibroblasts and collagen and glycosaminoglycans of the lamina propria. 7, 9, 12 There is reduced collagenolytic effect due to reduction in Calcium ion influx and consequent increase in extracellular matrix (ECM) collagen. 2, 7, 9 Drugs tend to deposit within the gingival epithelium and have a greater effect. 9 Another mechanism involves mast cells in inflammation which stimulates fibroblast proliferation, ECM synthesis and degradation.
14 Histologically epithelial and mesenchymal interaction that leads to greater ECM deposition. 
CONCLUSION
In this small study, the prevalence of amlodipine induced gingival overgrowth was low. Nevertheless, DIGO due to amlodipine was significantly associated with dose and duration of amlodipine use. So, the patients prescribed with the drug should be monitored regularly and treated when the GO occurs. Therefore, regular follow up and assessment of GO must be done in patients taking amlodipine.
